Literature DB >> 1514037

Ocular and systemic determination of IL-1 beta and tumour necrosis factor in a patient with ocular inflammation.

G N Palexas1, G Sussman, N H Welsh.   

Abstract

Cytokines such as interleukin-1 beta (IL-1 beta) and tumour necrosis factor (TNF) may play an important role in ocular inflammation. We studied a patient with clinical features of sympathetic ophthalmia secondary to previous penetrating ocular injuries, and compared the ocular and systemic levels of IL-1 beta and TNF to control serum, and correlated these findings to histopathological sections of the patient's eye. Histology showed the presence of a diffuse chronic inflammatory infiltrate within the choroid and in a perivascular distribution in the retina. The significantly elevated ocular and systemic levels of IL-1 beta and TNF suggest that there is not only a localized ocular response but a systemic response as well. The presence of IL-1 beta TNF may play a role in the pathogenesis of ocular inflammation once the blood ocular barrier has been breached and ocular antigens have been exposed to the systemic immune system.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1514037     DOI: 10.1111/j.1365-3083.1992.tb01645.x

Source DB:  PubMed          Journal:  Scand J Immunol Suppl        ISSN: 0301-6323


  6 in total

1.  Systemic CD4(+) T cell phenotype and activation status in intermediate uveitis.

Authors:  C C Murphy; L Duncan; J V Forrester; A D Dick
Journal:  Br J Ophthalmol       Date:  2004-03       Impact factor: 4.638

Review 2.  Mitochondrial oxidative stress initiates visual loss in sympathetic ophthalmia.

Authors:  Yutaka Kaneko; Narsing A Rao
Journal:  Jpn J Ophthalmol       Date:  2012-04-03       Impact factor: 2.447

3.  Evaluation of potential retinal toxicity of adalimumab (Humira).

Authors:  Miltiadis Tsilimbaris; Vasilios F Diakonis; Irini Naoumidi; Spyridon Charisis; Iraklis Kritikos; George Chatzithanasis; Thekla Papadaki; Sotiris Plainis
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-03-19       Impact factor: 3.117

4.  Immunopathologic processes in sympathetic ophthalmia as signified by microRNA profiling.

Authors:  Yutaka Kaneko; Guey Shuang Wu; Sindhu Saraswathy; Daniel V Vasconcelos-Santos; Narsing A Rao
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-06-28       Impact factor: 4.799

5.  A simple method for establishing adherent ex vivo explant cultures from human eye pathologies for use in subsequent calcium imaging and inflammatory studies.

Authors:  Sofija Andjelic; Xhevat Lumi; Zoltán Veréb; Natasha Josifovska; Andrea Facskó; Marko Hawlina; Goran Petrovski
Journal:  J Immunol Res       Date:  2014-09-04       Impact factor: 4.818

6.  Effective treatment of refractory sympathetic ophthalmia with glaucoma using adalimumab.

Authors:  Tomona Hiyama; Yosuke Harada; Yoshiaki Kiuchi
Journal:  Am J Ophthalmol Case Rep       Date:  2019-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.